Crinetics Pharmaceuticals, Inc. merger agreement

Nothing recorded as changed on this chain yet.

• 2026-08-288-Kresult0001140361-26-034857

• mergerAgreementregexinferred · 50%0001140361-26-034857

  “e total shares of common stock of Crinetics outstanding and entitled to vote, constituting a quorum to conduct business. The matters submitted for a shareholder vote at the Special Meeting and the related results are set forth below. Proposal No. 1 —To consider and vote on the proposal to adopt the Agreement and Plan o…”

• completionOfMergerregexinferred · 50%0001140361-26-034857

  “pursuant to the Merger Agreement (the “Transactions”). Set forth below are the voting results for Proposal No. 2, which was not approved by the requisite vote of Crinetics’ shareholders required to approve such proposal. However, Proposal No. 2 is advisory and non-binding, and is not a condition to completion of the Me…”

• pricePerShareregexinferred · 50%0001140361-26-034857

  “ange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share CRN…”

Nothing extracted yet.

Nothing extracted yet.

Subject

Crinetics Pharmaceuticals, Inc.

Counterparty

—

Minimum condition

—

Proration

Not indicated